STAT+: In private meeting, Trump officials push to onshore generic drugmaking

FDA Scientists Find Insufficient Evidence for Peptides, Undercutting RFK Jr.'s Push for Expanded Access

FDA career scientists have determined there is insufficient evidence to support the safety and efficacy of peptides being considered for pro

Trump’s drug price crusade puts Europe on guard

Pharma CEOs' silence enables Trump administration's assault on U.S. biomedical research, argues Washington editor

The article argues that pharma CEOs are complicit in the destruction of U.S. science by remaining silent as the Trump administration, partic

RFK Jr. pushes peptide deregulation; FDA scientists cite lack of safety evidence

Health Secretary Robert F. Kennedy Jr. is pushing to deregulate several peptides, making them more accessible through compounding pharmacies

White House Launches TrumpRx Direct-to-Consumer Drug Pricing Website

The White House has launched TrumpRx, a direct-to-consumer drug pricing website that allows patients to purchase certain medications at disc

Trump administration's kratom ban benefits rival supplement makers who lobbied for the change

The article reports on the Trump administration's move to ban a potent synthetic version of kratom, which benefits makers of rival botanical